Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 15/20 | 1.00 |
| ▸ | SRD5A1 | P18405 | 5/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Epristeride SCHEMBL61222 | 1.00 | SRD5A2 (1.00) | SRD5A2SRD5A1 | |
| Epristeride SCHEMBL16115063 | 1.00 | SRD5A2 (1.00) | SRD5A2SRD5A1 | |
| Epristeride SCHEMBL23833504 | 1.00 | SRD5A2 (1.00) | SRD5A2SRD5A1 | |
| Epristeride SCHEMBL9782857 | 0.99 | SRD5A2 (0.98) | SRD5A2SRD5A1 | |
| SCHEMBL9114229 | 0.93 | SRD5A2 (0.86) | SRD5A2SRD5A1 | |
| SCHEMBL8994092 | 0.91 | SRD5A2 (0.83) | SRD5A2SRD5A1 | |
| SCHEMBL8151554 | 0.91 | SRD5A2 (0.83) | SRD5A2SRD5A1 | |
| SCHEMBL8151553 | 0.91 | SRD5A2 (0.83) | SRD5A2SRD5A1 | |
| Epristeride SCHEMBL9782855 | 0.91 | SRD5A2 (0.83) | SRD5A2SRD5A1 | |
| SCHEMBL9391071 | 0.90 | SRD5A2 (0.82) | SRD5A2SRD5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0717618-B1 | STABILIZED TABLET FORMULATION | SMITHKLINE BEECHAM CORP (US) | 2002-11-06 | — | — | EP | claimed |
| EP-0633892-B1 | N-T-BUTYL-ANDROST-3,5-DIENE-17-beta-CARBOXAMIDE-3-CARBOXYLIC ACID POLYMORPH A | SMITHKLINE BEECHAM CORP (US) | 1999-05-26 | — | — | EP | claimed |
| US-5882681-A | N-T-BUTYL-ANDROST-3,5-DIENE-17.BETA.-CARBOXAMIDE-3-CARBOXYLIC ACID, FATTY ACID STABILIZING LUBRICANT. | SMITHKLINE BEECHAM CORPORATION (US) | 1999-03-16 | — | — | US | claimed |
| EP-0717618-A4 | STABILIZED TABLET FORMULATION | SMITHKLINE BEECHAM CORP (US) | 1997-06-04 | — | — | EP | claimed |
| US-5596109-A | BENIGN PROSTSTIC HYPERTROPY USING STEROID DERIVATIVES | SMITHKLINE BEECHAM CORPORATION (US) | 1997-01-21 | — | — | US | claimed |
| EP-0521080-B1 | SYNERGISTIC COMPOSITIONS | SMITHKLINE BEECHAM CORP (US) | 1996-12-11 | — | — | EP | claimed |
| EP-0684765-A4 | TREATING ALOPECIA BY ADMINISTERING 5-ALPHA-REDUCTASE INHIBITING COMPOUNDS. | SMITHKLINE BEECHAM CORP (US) | 1996-12-04 | — | — | EP | claimed |
| EP-0717618-A1 | STABILIZED TABLET FORMULATION | SMITHKLINE BEECHAM CORPORATION (US) | 1996-06-26 | — | — | EP | claimed |
| US-5516768-A | Uncompetitive inhibition of steroid and 5α-reductose | SMITHKLINE BEECHAM CORPORATION (US) | 1996-05-14 | — | — | US | claimed |
| EP-0684765-A1 | TREATING ALOPECIA BY ADMINISTERING 5-ALPHA-REDUCTASE INHIBITING COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-12-06 | — | — | EP | claimed |
| WO-1995006461-A1 | STABILIZED TABLET FORMULATION | SMITHKLINE BEECHAM CORPORATION (US) | 1995-03-09 | — | — | WO | claimed |
| EP-0633892-A1 | N-T-BUTYL-ANDROST-3,5-DIENE-17$g(b)-CARBOXAMIDE-3-CARBOXYLIC ACID POLYMORPH A | SMITHKLINE BEECHAM CORPORATION (US) | 1995-01-18 | — | — | EP | claimed |
| EP-0633781-A1 | COMPOSITIONS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERTROPHY | SMITHKLINE BEECHAM CORPORATION (US) | 1995-01-18 | — | — | EP | claimed |
| WO-1994017663-A1 | TREATING ALOPECIA BY ADMINISTERING 5-ALPHA-REDUCTASE INHIBITING COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-08-18 | — | — | WO | claimed |
| WO-1993019758-A1 | COMPOSITIONS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERTROPHY | SMITHKLINE BEECHAM CORPORATION (US) | 1993-10-14 | — | — | WO | claimed |
| WO-1993019081-A1 | N-T-BUTYL-ANDROST-3,5-DIENE-17β-CARBOXAMIDE-3-CARBOXYLIC ACID POLYMORPH A | SMITHKLINE BEECHAM CORPORATION (US) | 1993-09-30 | — | — | WO | claimed |
| WO-1993019080-A1 | N-T-BUTYL-ANDROST-3,5-DIENE-17β-CARBOXAMIDE-3-CARBOXYLIC ACID POLYMORPH B | SMITHKLINE BEECHAM CORPORATION (US) | 1993-09-30 | — | — | WO | claimed |
| EP-0289327-B1 | STEROID 5-ALPHA-REDUCTASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1991-12-18 | — | — | EP | claimed |
| US-5017568-A | Enzyme inhibitors, carboxylation | SMITHKLINE BEECHAM CORPORATION (US) | 1991-05-21 | — | — | US | claimed |
| EP-0289327-A2 | Steroid 5-alpha-reductase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1988-11-02 | — | — | EP | claimed |